Skip to content

Guest Presentation: New Framework for Stem Cell Analysis

Dortmund, 27th January 2023

Understanding and predicting the behaviour of cells in normal, regenerative and pathological contexts – these are the goals of the Allen Institute for Cell Science. To achieve this, the non-profit research organisation develops multi-scale visual models of cell organisation, dynamics and activity. Its software programmes are freely accessible to researchers worldwide (open source). They are part of the Allen Cell Explorer, a portal for cells, cell biology, data and tools. The portal provides insight into the organisational diversity of human stem cells and delivers matching open data, cell lines, plasmids and models. Human stem cells from the test tube, so-called induced pluripotent stem cells, are the subject of a recently published paper in Nature.

How does a subset of expressed genes dictate cellular phenotype – the visible properties of cells? Finding the answer to this question is a considerable challenge for scientists due to the large number of molecules involved, their combinatorics and the abundance of cellular behaviors that determine this phenotype. Scientists at the Allen Institute for Cell Science have recently succeeded in developing a framework for the analysis of integrated intracellular organization and its variations in human iPS cells, based on datasets of 200,000 living cells in 3D and a set of 25 key structures.

 A framework is a basic software scaffold that developers can use to build computer applications. The framework developed at the Allen Institute for Cell Science allows for programming analysis software that converts raw image data of iPS cells and their structures into dimensionally reduced, quantitative analyses.

Portrait Susanne Rafelski.

Dr Susanne Rafelksi is a biochemist and has been Deputy Director of Scientific Programmes at the Allen Institute for Cell Science since 2020.

How the framework will exactly advance stem cell analysis is the topic of Dr. Susanne Rafelski's presentation, "Integrated intracellular organization and its variations in human iPS cells," at ISAS on February 7.

Tuesday, February 7
10.30 am
Webex

https://t1p.de/rk032
Meeting ID: 2730 175 0712
Password: uMegm3Dw5B5

Rafelski is deputy director of scientific programmes at the Seattle institute – and corresponding author of the Nature publication. ISAS has a cooperation with the Allen Institute for Cell Science. The AMBIOM working group led by Dr Jianxu Chen is in charge here. The 34-year-old worked at the Allen Institute for Cell Science for four years before joining ISAS.

(Sara Rebein)

Share

Further articles

8th September 2025

3 Questions for Susmita Ghosh

How does gut microbiota affect the immune system? Susmita Ghosh conducts research on proteins and immune cells at ISAS. In this interview, the biologist talks about her work and explains how gut flora and the immune system could affect the outcomes of a stroke.

Susmita Ghosh sitzt am ultrasensitiven Massenspektrometer und stellt eine Proben ein.
8th September 2025

Gut Flora & Stroke: How Microorganisms Influence Our Immune System

Which factors can activate immune cells after a stroke? This question was investigated by researchers at University Hospital Essen and ISAS. Their work focused on the gut microbiota.

23rd July 2025

3 Questions for Dr Ali Ata Tuz

In his doctorate, Dr Ali Ata Tuz researched the causes of immunodeficiency after strokes and was already working closely with ISAS at the time. Following this, he subsequently devoted himself to the behaviour of immune cells in the bioimaging research group at ISAS. In this interview, the physician talks about his path from the clinic to application-oriented basic research.

Dr. Ali Ata Tuz sitzt am Konfokalmikroskop und schaut frontal in die Kamera.. Auf dem Bildschirm nebem dem Mirkoskop sind in grün und violett Mikroskopaufnahmen von einer Probe im Mikroskop zu sehen.
8th July 2025

Heart Failure Rarely Occurs on Its Own: ISAS Researchers Develop New Treatment Pillars

The symptoms, subsequent problems and therapeutic challenges of patients with heart failure are increasingly challenging for general practitioners and cardiologists. Doctors are limited in their choice of treatment options, especially for patients with additional diseases. At ISAS, researchers are therefore focussing on broadening the therapeutic spectrum.

Prof. Dr. Kristina Lorenz.
25th June 2025

New Ionisation Method: From Open Questions to Closed Plasma

Mass spectrometry only works with electrically charged, i.e. ionised, particles. Researchers often use plasma for this purpose. In a series of publications, scientists from the Miniaturisation Research Group have shed new light on this ionisation method and presented a completely new type of plasma. This does not require a continuous gas flow and is therefore particularly resource-efficient.

Cayian Tian adjusts the gas supply to the plasma.
11th June 2025

“We essentially ask ourselves the same questions”

In the ISAS cooperation project “The Secret World of the Immune System”, ISAS researchers and artists from the storyLab kiU at Dortmund University of Applied Sciences and Arts brought microscope data to life in an immersive space. Lennart Oberscheidt, research associate and visual effects (VFX) supervisor at storyLab kiU, talks about the special features of the project and the similarities between art and research in an interview.

30th May 2025

What Can't Be Missing From Your Project, Laxmikanth Kollipara?

In many research projects, there is one thing that is essential for success. Perhaps a rare sample or a special device? For Dr Laxmikanth Kollipara, that one thing is a very special pillar from the PIPMet project.

Dr Laxmikanth Kollipara stands in the laboratory holding a silver-coloured column. In the background are HPLC systems.
14th May 2025

“Moving to ISAS changed my whole view on mass spectrometry”

Prof Dr Miloš Filipović is researching the connection between ageing processes and gasotransmitter signalling pathways, in particular hydrogen sulphide. The biochemist headed the ERC Sulfaging group at ISAS from October 2020 until February 2025, at which point he was appointed to the University of Glasgow in Scotland. In this interview, he looks back on the past four and a half years in Dortmund and talks about his experiences at ISAS.

Dr. habil. Milos Filipovic.
30th April 2025

Humboldt Fellow Prof Dr Xiaowei Xu started at ISAS in March

Prof Dr Xiaowei Xu from the Chinese Guangdong Cardiovascular Institute is researching the clinical application of artificial intelligence (AI) in the context of cardiovascular diseases. For 18 months in total, he will be researching various AI methods for analysing cell images as a Humboldt Fellow at ISAS.

Prof Dr Xiaowei Xu in front of the ISAS city building.